UTI Asset Management Company carries a clean audit record, zero debt, and a board with no promoter to answer to. Three things colour the picture: dividends that outrun the cash the business generates, a ₹133 crore exceptional charge that reshapes FY26 profit, and a handful of unresolved regulatory notices now several years old.
Key findings
- Dividends consume nearly all profit and exceed free cash flow
Minor- Over the ten years through FY26, cumulative dividends of ₹615 crore represented 168% of cumulative free cash flow of ₹366 crore. The Board recommended a final dividend of ₹40 per share for FY26, a 95% payout of PAT, following payout ratios of 94% in FY25 and 99.6% in FY24. The CEO stated in March 2026 that the company holds \~₹4,000-4,500 crore in cash and investments and has “no other plans to do anything dramatic with the cash at this point of time” beyond the dividend trend and maintaining liquidity for potential M&A. - Exceptional charges of ₹133 crore reshaped FY26 profit
Minor- UTI AMC recognised a total exceptional charge of ₹104.28 crore in FY26 for a Voluntary Retirement Scheme covering 184 employees, comprising ₹84.64 crore VRS provision, ₹2.89 crore additional gratuity, and ₹16.75 crore pension liability. An incremental gratuity liability of ₹4.26 crore was recognised as an exceptional item due to the New Labour Codes effective 21 November 2025, and employee benefit expenses included a one-time charge of ₹24.94 crore from a Board-approved revision in family pension benefits on 23 September 2025. - Audit opinions are clean, but audit-trail gaps and loans without repayment schedules recur
Minor- The standalone audit opinion was unqualified in every year from FY2020 to FY2026. Yet the auditor reported that the audit trail feature in the accounting software was not enabled at the application layer for revenue, PPE, and certain other areas from 1 May 2023 to 15 January 2024 for data changes by users with privileged access. Separately, the Company granted loans to parties other than subsidiaries, joint ventures, and associates where no schedule of repayment of principal or payment of interest was stipulated, and the auditor was unable to comment on the regularity of repayment in FY2024, FY2025, and FY2026. - Investment management fees dominate revenue and are a recurring Key Audit Matter
Minor- Revenue from investment management fees was a Key Audit Matter, an area requiring the most auditor judgement, in every year from FY2022 to FY2026, with the auditor citing inherent risk from manual input of contractual terms and AUM calculations across multiple schemes. On a consolidated basis, investment management fees represented 72.39% of the Group's total revenue from operations in FY2026. One customer contributed more than 10% of total revenue in the same year. - The group operates a layered offshore structure with a Guernsey holding company
Minor- UTI International Limited, the sole material subsidiary, is incorporated in Guernsey and itself has four subsidiaries outside India, forming a five-entity offshore chain. Its consolidated total income fell from GBP 1,57,42,896 in FY25 to GBP 19,31,981 in FY26, and it swung from a consolidated net profit of GBP 14,07,262 to a consolidated net loss of GBP 1,18,96,636. Two domestic AIF subsidiaries, UTI Structured Debt Opportunities Fund II and III, ceased to be subsidiaries on 24 December 2025 and 25 March 2026 respectively after final distributions and sale of the Company’s investment. - Two regulator show-cause notices from FY2020 remain unresolved
Minor- SEBI issued a show-cause notice in January 2020 alleging violation of SEBI FPI and MF Regulations regarding India Debt Opportunities Fund Limited Mauritius and a domestic scheme, with a penalty under section 15 HB of the SEBI Act 1992 of minimum ₹1 lakh and maximum ₹1 crore; the Company filed replies in March 2020 denying the allegations and the matter remains pending as of FY2023. PFRDA issued a separate show-cause notice in February 2020 alleging violations of the PFRDA Act and POP Regulations, with penalty up to ₹1 crore; the Company filed a reply in February 2020 denying the allegations. A ₹5 lakh PFRDA penalty for violation of POP Regulations was paid on 20 May 2022 and no appeal was preferred. - Contingent liabilities are stable and long-running, while fund commitments are disclosed for FY26
Minor- Income Tax demands for AY 2009-10 of ₹5.26 crore and AY 2010-11 of ₹2.28 crore have remained unchanged from FY2020 through FY2026. A suit filed in 2003 by ex-Registrars & Transfer Agents seeking ₹3.19 crore, with a cross-suit for ₹1.37 crore, results in a net contingent liability of ₹1.82 crore; the case was transferred to City Civil Court, Mumbai on 29 January 2024. Capital commitments in FY2026 include ₹39.50 crore to Structured Debt Opportunity Fund IV, ₹21.00 crore to UTI Asset Reconstruction Opportunities Fund I, and ₹20.45 crore to LICHFL Real Estate Debt Opportunities Fund I, alongside a continuing ₹40 crore commitment to UTI Alternatives Private Limited. - Auditor rotated to B S R & Co. LLP in FY22, now proposed for a second term
Minor- M/s. G. D. Apte & Co. served as statutory auditor for FY2020-21 and was replaced by M/s. B S R & Co. LLP effective from the conclusion of the 18th AGM on 28 July 2021 for a five-year term. The Board proposed re-appointment of B S R & Co. LLP for a second five-year term, with proposed audit remuneration for FY2026-27 of ₹1,03,00,000. UTI International Limited appointed M/s. KPMG Channel Islands Limited as its statutory auditor on 21 July 2022. - No promoter, routine board governance, and minor insider-trading compliance lapses
Clean- UTI AMC has had zero promoter shareholding since at least FY2020-21, with all shareholder resolutions voted entirely by public institutions and non-institutions. The Board had 6 out of 9 directors as Non-Executive Independent Directors as of 31 March 2026, with separate posts of Chairperson and MD & CEO who are not related. The Secretarial Compliance Report for FY2025-26 recorded five instances of employee non-compliance with SEBI insider-trading regulations, comprising one instance of trading without pre-clearance and delayed reporting, two instances of trading without pre-clearance, and two instances of delayed trade reporting; warnings were issued.
What to watch
- Cash deployment. Deployment of the \~₹4,000-4,500 crore cash and investment pile referenced by the CEO in the Q4 FY26 transcript.
- Auditor re-appointment vote. Shareholder vote on re-appointment of B S R & Co. LLP for a second five-year term at the 23rd AGM, notice dated 24 June 2026.
- Audit trail. Whether the audit trail facility is enabled and operating at the database level for all accounting software for the full financial year ending 31 March 2027.
- Loans without repayment schedules. Whether the loans granted without stipulated repayment schedules are regularised or repaid as at 31 March 2027.
- SEBI show-cause notice. Resolution of the SEBI show-cause notice dated January 2020, pending as of the FY2023-24 Annual Report.
- PFRDA show-cause notice. Resolution of the PFRDA show-cause notice dated February 2020, last disclosed as pending in the FY2020-21 Annual Report.
- Income Tax appeal. Pending hearing of the Income Tax department's appeal before the High Court for the AY 2009-10 demand of ₹5.26 crore, as reported in the FY2025-26 Annual Report.
- AIUTEA pension case. Pending hearing of the AIUTEA Special Leave Petition before the Supreme Court regarding the pension option, as reported in the FY2023-24 Annual Report.
Bottom line: This is a debt-free, professionally governed asset manager with a seven-year run of unqualified audit opinions and no promoter to answer to. The record asks two questions of a reader: whether dividends that consistently outstrip free cash flow are sustainable without dipping into the cash pile, and whether the unresolved regulatory notices from 2020 ever crystallise into something more than correspondence. Watch the cash deployment choice and the SEBI show-cause notice for the answer.